ArticleFrontiers in immunology2025

Quantitative nodal burden as a predictive marker for chemotherapy benefit in postoperative ampullary adenocarcinoma: a multi-institution population-based study.

Zheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.